Skip to main content
. 2021 Apr 2;12(1):80–88. doi: 10.1016/j.jceh.2021.03.010

Figure 1.

Figure 1

Representative flow cytometry pictures of the healthy control (upper panel) and patient with CLD (lower panel). Panel a shows gating of MSCs at passage 3. Panel b shows MSCs positive for phenotypic marker staining for CD90, CD73 and CD105 and negative for CD34, CD45 and viability marker 7-AAD. 7-AAD, 7-aminoactinomycin D; MSC, mesenchymal stem cell; CLD, chronic liver disease.